slld61.JPG

External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual & Semi-Automated External Defibrillators, Fully Automated External Defibrillators, and Wearable Cardioverter Defibrillators), By End-Users, Region, And Segment Forecasts, 2025-2034

Report Id: 1158 Pages: 190 Published: 22 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

The External Defibrillators Market Size is valued at 3348.0 Million in 2023 and is predicted to reach 6676.6 Million by the year 2031 at an 9.12% CAGR during the forecast period for 2024-2031. 

External Defibrillators Market

In recent years, the use of automated external defibrillators has been promoted as a part of the chain of survival to improve outcomes for adult cardiac arrest victims. An automated external defibrillator (AED) is defined as a lightweight, portable device that carries an electric shock through the chest to the heart. The shock can potentially stop an irregular heartbeat (arrhythmia) and allow a normal rhythm to resume following sudden cardiac arrest (SCA).

Factors such as the growing focus toward public access defibrillator (PAD) by the public & private organizations are expected to drive the market growth over the forecast period. Moreover, growing technological advancements in defibrillator devices, speedily rising geriatric population with higher risk of targeted diseases, and increase in the incidence of cardiac diseases is further estimated to boost the market growth. The market is further driven by other significant factors, such as the increasing prevalence of cardiovascular diseases, including coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions across the globe.

Market Segmentation

The Global External Defibrillators market is categorized on the basis of product, End-user, and region. On the basis of product type, the market is segmented into Manual & Semi-Automated External Defibrillators, Fully Automated External Defibrillators, and Wearable Cardioverter Defibrillators. On the basis of End-user, the market is segmented into Hospitals, Clinics, & Cardiac Centers, Prehospital Care Settings, Public Access Markets, Alternate Care Facilities, and Home Care Settings. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.

Competitive Landscape

Some of The Key Players in The External Defibrillators Market:

  • Edwards Lifesciences Corporation
  • Gore & Associates, Inc.
  • BD (Becton Dickinson)
  • CryoLife, Inc.
  • Baxter International, Inc.
  • Johnson & Johnson (Medical Devices Business Services, Inc.)
  • Aesculap, Inc. (a B. Braun company)
  • Nurami Medical Nanofiber Technology
  • Medtronic
  • FOC Medical S.A.
  • Admedus
  • Bone Bank Allografts
  • Braile Biomédica
  • Glycar SA Pty Ltd.
  • LeMaitre Vascular, Inc.
  • Medprin Regenerative Medical Technologies Co., Ltd.
  • CorMatrix, Inc.
  • Terumo Corporation
  • Lamed GmbH
  • South America Implants S.A
  • Other Prominent Players

The External Defibrillators Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 3348.0 Million

Revenue Forecast In 2031

USD 6676.6 Million

Growth Rate CAGR

CAGR of 9.12% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

A.M.I. ITALIA , Bexen Cardio, BPL Medical Technologies, Cardia International B.V., Cardiac Science Corporation, Concern AXION Ltd., Defibtech, LLC, E & M Electromedicine, Koninklijke Philips N.V., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, SCHILLER AG, Stryker Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., ZOLL Medical Corporation, Mediana Co. Ltd., PRIMEDIA (Metrax GmbH), Promed, Opto Circuits India Ltd., CU Medical System Inc., Shenzhen XFT Medical Limited, and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Global External Defibrillators Market Segmentation

Global External Defibrillators Market Based on Product

  • Manual & Semi-Automated External Defibrillators
  • Fully Automated External Defibrillators
  • Wearable Cardioverter Defibrillators 

External Defibrillators Market

Global External Defibrillators Market Based on End-user

  • Hospitals
  • Clinics, & Cardiac Centers
  • Prehospital Care Settings
  • Public Access Markets
  • Alternate Care Facilities
  • Home Care Settings

Global External Defibrillators Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Email field cannot be blank!(Use email format)
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7818
Security Code field cannot be blank!
Frequently Asked Questions

Clinical Trials Manufacturing & Supply Outsourcing Market Size is valued at USD 13.4 Bn in 2024 and is predicted to reach USD 22.4 Bn by the year 2034

Almac Group Limited, Patheon, Thermo Fischer Scientific, Klifo, Movianto, Eurofins Scientific, Clinigen, Spaulding Clinical, Singota, Symeres, Ardena,

Service Type, Phase Type and End-User are the key segments of the Clinical Trials Manufacturing and Supply Outsourcing Market.

North American region is leading the Clinical Trials Manufacturing and Supply Outsourcing Market.

Clinical Trials Manufacturing and Supply Outsourcing Market is expected to grow at a 7.3% CAGR during the forecast period for 2025-2034.